Folgen
Pamela J Shaw
Pamela J Shaw
Professor of Neurology, University of Sheffield
Bestätigte E-Mail-Adresse bei sheffield.ac.uk
Titel
Zitiert von
Zitiert von
Jahr
Amyotrophic lateral sclerosis
O Hardiman, A Al-Chalabi, A Chio, EM Corr, G Logroscino, W Robberecht, ...
Nature reviews Disease primers 3 (1), 1-19, 2017
20982017
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
E Majounie, AE Renton, K Mok, EGP Dopper, A Waite, S Rollinson, ...
The Lancet Neurology 11 (4), 323-330, 2012
14012012
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial
SC Bourke, M Tomlinson, TL Williams, RE Bullock, PJ Shaw, GJ Gibson
The Lancet Neurology 5 (2), 140-147, 2006
13022006
Pathological TDP‐43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations
IRA Mackenzie, EH Bigio, PG Ince, F Geser, M Neumann, NJ Cairns, ...
Annals of Neurology: Official Journal of the American Neurological …, 2007
12472007
Adaptation to culture of human embryonic stem cells and oncogenesis in vivo
DEC Baker, NJ Harrison, E Maltby, K Smith, HD Moore, PJ Shaw, ...
Nature biotechnology 25 (2), 207-215, 2007
8002007
Oxidative stress in ALS: key role in motor neuron injury and therapeutic target
SC Barber, PJ Shaw
Free Radical Biology and Medicine 48 (5), 629-641, 2010
7662010
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
L Ferraiuolo, J Kirby, AJ Grierson, M Sendtner, PJ Shaw
Nature Reviews Neurology 7 (11), 616-630, 2011
7262011
White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury
MS Fernando, JE Simpson, F Matthews, C Brayne, CE Lewis, R Barber, ...
Stroke 37 (6), 1391-1398, 2006
6772006
Genome-wide analyses identify KIF5A as a novel ALS gene
A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ...
Neuron 97 (6), 1267-1288, 2018
6642018
Controversies and priorities in amyotrophic lateral sclerosis
MR Turner, O Hardiman, M Benatar, BR Brooks, A Chio, M De Carvalho, ...
The Lancet Neurology 12 (3), 310-322, 2013
6622013
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ...
Nature genetics 48 (9), 1043-1048, 2016
6422016
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions
VM Van Deerlin, PMA Sleiman, M Martinez-Lage, A Chen-Plotkin, ...
Nature genetics 42 (3), 234-239, 2010
6392010
Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target
SC Barber, RJ Mead, PJ Shaw
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1762 (11-12 …, 2006
6092006
Neurologic and neuropsychological morbidity following major surgery: comparison of coronary artery bypass and peripheral vascular surgery.
PJ Shaw, D Bates, NE Cartlidge, JM French, D Heaviside, DG Julian, ...
Stroke 18 (4), 700-707, 1987
6041987
The role of mitochondria in amyotrophic lateral sclerosis
EF Smith, PJ Shaw, KJ De Vos
Neuroscience letters 710, 132933, 2019
5772019
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
TM Miller, ME Cudkowicz, A Genge, PJ Shaw, G Sobue, RC Bucelli, ...
New England Journal of Medicine 387 (12), 1099-1110, 2022
5552022
Amyotrophic lateral sclerosis
EL Feldman, SA Goutman, S Petri, L Mazzini, MG Savelieff, PJ Shaw, ...
The Lancet 400 (10360), 1363-1380, 2022
5442022
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
T Miller, M Cudkowicz, PJ Shaw, PM Andersen, N Atassi, RC Bucelli, ...
New England Journal of Medicine 383 (2), 109-119, 2020
5402020
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B)
N Parkinson, PG Ince, MO Smith, R Highley, G Skibinski, PM Andersen, ...
Neurology 67 (6), 1074-1077, 2006
5292006
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model
HJ Westeneng, TPA Debray, AE Visser, RPA van Eijk, JPK Rooney, ...
The Lancet Neurology 17 (5), 423-433, 2018
5052018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20